APTUS at HOME

  • Research type

    Research Study

  • Full title

    Aptus at home: Co-design of a home-based monitoring system for anaemia

  • IRAS ID

    233542

  • Contact name

    Jennifer Stuart

  • Contact email

    jennifer@entia.co

  • Sponsor organisation

    Entia Ltd

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    The main objective of the trial is to co-design a home-based monitoring system for anaemia and evaluate the usability and physical validation of the Aptus device and its application for home use management of anaemia. Users participating in the trial will be expected to do blood analysis using capillary blood from a finger prick, complete questionnaires at specific time-points and be involved in 1 to 1 interviews or focus groups via phone, skype or in person.

    Additional information requested will include but not be restricted to menstrual cycle, smoking habits, pregnancy status, anaemia and contraceptive medication, or any other underlying conditions that may affect their blood results. The additional information collected will be important for building an app based service to monitor patient conditions relating to anaemia. Monitoring trends and tracking results will potentially be part of the usability testing.
    Data from this evaluation will be used to support research and development of the Aptus home range of devices.
    The study will be advertised on social media platforms, posters and flyers will also be posted in public locations. Participation will be voluntary and participants will be consented to the study. Posters and flyers will target individuals that have a diagnosed case of anaemia. A free device will be given to all participants who complete the study and the information gained may help other people and participants in the future. Participants’ travel expenses to and from interviews will also be reimbursed by Entia Ltd.

  • REC name

    East Midlands - Nottingham 1 Research Ethics Committee

  • REC reference

    17/EM/0479

  • Date of REC Opinion

    30 Jan 2018

  • REC opinion

    Further Information Favourable Opinion